Source comparison
PT-141 40s Age Specific Protocol: Dosing Comparison
25–39 1.5mg 1.5–2.0mg 48–72 hours 45–60 minutes Standard MC4R density, faster clearance, robust eNOS activity 40–50 0.5mg 0.75–1.25mg 72–96 hours 90–120 minutes Reduced MC4R density, slower clearance, blunted nitric oxide response 50+ 0.5–1.0mg 96+ hours 120–1
This comparison does not assign a generated winner or score.
- 25–39
- 1.5mg
- 1.5–2.0mg
- 48–72 hours
- 45–60 minutes
- Standard MC4R density, faster clearance, robust eNOS activity
- 40–50
- 0.5mg
- 0.75–1.25mg
- 72–96 hours
- 90–120 minutes
- Reduced MC4R density, slower clearance, blunted nitric oxide response
- 50+
- 0.5–1.0mg
- 96+ hours
- 120–150 minutes
- Further MC4R decline, significantly slower metabolism, cardiovascular precaution
- 40–50 with CV history
- 0.25mg
- 0.5–0.75mg
- 120+ minutes
- Cardiovascular load mitigation, lowest effective receptor engagement